Subkutánní infliximab – zlepšování výsledků léčby pacientů s IBD
Published in:
Gastroent Hepatol 2026; 80(2): 175-177
Category:
Labels
Paediatric gastroenterology Gastroenterology and hepatology SurgeryArticle was published in
Gastroenterology and Hepatology
2026 Issue 2
- The Importance of Limosilactobacillus reuteri in Administration to Diabetics with Gingivitis
- Safety and Tolerance of Metamizole in Postoperative Analgesia in Children
- Metamizole in perioperative treatment in children under 14 years – results of a questionnaire survey from practice
- Obstacle Called Vasospasm: Which Solution Is Most Effective in Microsurgery and How to Pharmacologically Assist It?
Most read in this issue
- Benefits and risks of HCV cure
- Diagnosis and therapy of hepatitis B virus infection: Czech national guidelines
- Mapování horizontu léčby ulcerózní kolitidy v éře inhibitorů IL-23
- Neutrophil-to-lymphocyte ratio refl ects infl ammatory phenotypes of alcohol-associated hepatitis: diff erences between mild and severe dis ease